[Federal Register Volume 74, Number 173 (Wednesday, September 9, 2009)]
[Notices]
[Pages 46440-46441]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-21554]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0409]


Request for Notification From Industry Organizations Interested 
in Participating in the Selection Process for a Pool of Nonvoting 
Industry Representatives for the Risk Communication Advisory Committee 
and Request for Nominations for Nonvoting Industry Representatives for 
the Risk Communication Advisory Committee

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is requesting that

[[Page 46441]]

any industry organizations interested in participating in the selection 
of a pool of nonvoting industry representative candidates available to 
serve as temporary nonvoting members on its Risk Communication Advisory 
Committee (the Committee) for the Office of the Commissioner notify FDA 
in writing. A nominee may either be self-nominated or nominated by an 
organization to serve as a nonvoting industry representative. 
Nominations for the pool will be accepted effective with this notice.

DATES:  Any industry organization interested in participating in the 
selection of a pool of appropriate candidates for temporary nonvoting 
membership to represent industry interests must send a letter stating 
the interest to FDA by October 9, 2009, for vacancies listed in the 
notice. Concurrently, nomination material for prospective candidates 
should be sent to FDA by October 9, 2009.

ADDRESSES:  All letters of interest and nominations should be submitted 
in writing to Lee L. Zwanziger (see FOR FURTHER INFORMATION CONTACT).

FOR FURTHER INFORMATION CONTACT:  Lee L. Zwanziger, Office of Policy, 
Planning and Budget, Office of the Commissioner, Food and Drug 
Administration, 5600 Fishers Lane, rm. 14-90, 301-827-2895, fax: 301-
827-4050, <a href="/cdn-cgi/l/email-protection#7e2c3d3f3d3e181a1f5016160d50191108"><span class="__cf_email__" data-cfemail="3d6f7e7c7e7d5b595c1355554e135a524b">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION:  The agency requests nominations for a pool 
of nonvoting industry representative candidates for the Risk 
Communication Advisory Committee.

I. The Risk Communication Advisory Committee

    The Risk Communication Advisory Committee advises the Commissioner 
of Food and Drugs and designees on strategies and programs designed to 
communicate with the public about the risks and benefits of FDA-
regulated products so as to facilitate optimal use of these products. 
The Committee also reviews and evaluates research relevant to such 
communication to the public by both FDA and other entities. The 
Committee also facilitates interactively sharing risk and benefit 
information with the public to enable people to make informed 
independent judgments about use of FDA-regulated products.
    The FDA hopes to identify a pool of individuals who would have 
expertise in risk communication and would be identified with the 
interests of various segments of regulated industry. The Commissioner, 
or designee, shall have the authority to select one or more individuals 
to serve temporarily as nonvoting members; the number of temporary 
members selected for a particular meeting will depend on the meeting 
topic(s).

II. Selection Procedure

    Any industry organization interested in participating in the 
selection of appropriate nonvoting member candidates to represent 
industry interests should send a letter stating that interest to the 
FDA contact (see ADDRESSES) within 30 days of publication of this 
document (see DATES). Within the subsequent 30 days, FDA will send a 
letter to each organization that has expressed an interest, attaching a 
complete list of all such organizations, and a list of all nominees 
along with their current resumes. The letter will also state that it is 
the responsibility of the interested organizations in each industry 
segment to confer with one another and to select one or two candidates 
(allowing for an alternate) from the segment for the pool within 60 
days after the receipt of the FDA letter. For this purpose, 
``segments'' should be understood in correspondence with the eight 
links listed on the FDA Web site: Food; drugs; medical devices; 
vaccines, blood and biologics; animal and veterinary; cosmetics; 
radiation-emitting products; and tobacco products (http://www.fda.gov). 
The interested organizations are not bound by the list of nominees in 
selecting candidates. However, if no individuals are selected within 60 
days, the Commissioner of Food and Drugs will select temporary 
nonvoting members as needed to represent industry interests.

III. Application Procedure

    Individuals may self-nominate and/or an organization may nominate 
one or more individuals to serve as a nonvoting industry 
representative. Within the 30 days, the following information should be 
sent to the FDA contact person: A current curriculum vitae of each 
nominee, current business and/or home address, telephone number, e-mail 
address, and the name of the committee of interest. FDA will forward 
all nominations to the organizations expressing interest in 
participating in the selection process for the committee. (Persons who 
nominate themselves as nonvoting industry representatives will not 
participate in the selection process).
    FDA has a special interest in ensuring that women, minority groups, 
individuals with physical disabilities and small businesses are 
adequately represented on its advisory committees, and therefore, 
encourages, nominations for appropriately qualified candidates from 
these groups.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: September 2, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-21554 Filed 9-8-09; 8:45 am]
BILLING CODE 4160-01-S


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>